Identification of a molecular profile that may predict early relapse in patients undergoing multimodality therapy in muscle-invasive bladder cancer (MIBC). Diverse long-time progression-free survival ...
Doctors often monitor tumor markers in the blood to help diagnose and treat liver cancer. Alpha-fetoprotein (AFP) is the most common tumor marker that doctors monitor. Tumor markers, also called ...
The therapeutic strategy for choosing lenvatinib in systemic therapy for unresectable hepatocellular carcinoma. This is an ASCO Meeting Abstract from the 2022 ASCO Gastrointestinal Cancers Symposium.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results